The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease

Bone Marrow Transplant. 2023 Feb;58(2):215-218. doi: 10.1038/s41409-022-01872-7. Epub 2022 Nov 14.

Ming Wang^{1

2}, Bixia Wang^{1

2}, Lan-Ping Xu², Yu Wang², Xiao-Hui Zhang², Yi-Fei Cheng², Yu-Qian Sun², Yuan-Yuan Zhang², Yan-Rong Liu², Ying-Jun Chang², Kai-Yan Liu², Xiao-Jun Huang^{3

4

5}

¹ Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
² Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
³ Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. huangxiaojun@bjmu.edu.cn.
⁴ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. huangxiaojun@bjmu.edu.cn.
⁵ Peking-Tsinghua Center for Life Sciences, Beijing, China. huangxiaojun@bjmu.edu.cn.

No abstract available

Publication types